Torsemide and Ibrance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Torsemide (torsemide) and Ibrance (palbociclib). Common drug interactions include death among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Torsemide and Ibrance. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Torsemide?

Torsemide has active ingredients of torsemide. It is often used in high blood pressure. eHealthMe is studying from 33,072 Torsemide users. Check the latest studies of Torsemide.

What is Ibrance?

Ibrance has active ingredients of palbociclib. eHealthMe is studying from 104,434 Ibrance users. Check the latest studies of Ibrance.

On Jul, 16, 2026

72 people who take Torsemide and Ibrance together, and have interactions are studied.

Torsemide and Ibrance drug interactions.

What are the common drug interactions of Torsemide and Ibrance, by gender? *:

female:

Death
Diarrhoea
Depression
Muscular weakness (muscle weakness)
Platelet count decreased
Stomatitis (inflammation of mucous membrane of mouth)
Back pain
Malaise (a feeling of general discomfort or uneasiness)
Breast cancer metastatic
Malignant neoplasm progression (cancer tumour came back)

male:

Asthenia (weakness)
Fatigue (feeling of tiredness)
Headache (pain in head)

What are the common drug interactions of Torsemide and Ibrance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Otitis externa fungal (fungal infection of external ear)
Pneumonia
Hospitalisation
Tremor (trembling or shaking movements in one or more parts of your body)

50-59:

Alopecia (absence of hair from areas of the body)
Blood folate decreased
Blood glucose increased
Chest discomfort
Cough
Death
Diarrhoea
Dysphonia (speech disorder attributable to a disorder of phonation)
Dyspnoea (difficult or laboured respiration)
Ear infection

60+:

Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)
Stomatitis (inflammation of mucous membrane of mouth)
Back pain
Platelet count decreased
Breast cancer metastatic
Diarrhoea
Malignant neoplasm progression (cancer tumour came back)
Thrombocytopenia (decrease of platelets in blood)
Dyspnoea exertional (breathlessness or shortness of breath)

What are the existing conditions these people have? *

Breast Cancer Metastatic: 21 people, 29.17%
Breast Cancer Female: 15 people, 20.83%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 10 people, 13.89%
Breast Cancer: 9 people, 12.50%
Migraine (headache): 8 people, 11.11%
Sleep Disorder: 5 people, 6.94%
Pain: 5 people, 6.94%
Lymphoma (cancer that begins in immune system cells): 4 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Torsemide and Ibrance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously